Abstract: Electrochemotherapy is an innovative minimallyinvasive technique for treating cancer, which has already been used successfully in malignancies of the skin. In order to establish this method for an interstitial use, we developed a needle-shaped probe with four expandable electrodes, which can be used as percutaneous, image-guided, minimally invasive treatment option for malignant liver tumors. For evaluating the field expansion that depends on geometry parameters, we establish a quality factor G to rate deviations in production line and to determine how precise the intervention mus be carried out. Furthermore different voltage and wiring of the electrode can be rated.
Introduction
Interventional oncology, comprising a broad variety of minimally-invasive techniques for treating cancer patients is rapidly evolving. These techniques present an addition to conventional approaches such as resection and chemotherapy. However, most of these techniques, are either limited in effectiveness or by tumor size and location. An innovative treatment option is electrochemotherapy, which has already been used successfully in malignancies of the skin. So far, it has not been established for an interstitial use. The aim of this research project is the development of a percutaneous, image-guided application of the electrochemotherapy for use as minimally invasive treatment option for malignant liver tumors (prototype can bee seen in Fig. 2 ). During this project an evaluation has been developed to rate the geometric parameters and also later the effectivity of the therapy.
Methods
Electrochemotherapy is based on the concept of reversible electroporation, which is an established method to punctually and temporarily destabilize the lipid bilayer of cell membranes by creating a homogeneous electric field around the target cells. For the treatment of malignant skin lesions a field strength of about E = 1400 V /m (depends on quantity, frequency and pulse width) has been established as a working value. [1, 2] The electrical field depends on the permittivity , which is a material constant (see Eq. 1). For healthy tissue the permittivity can be looked up at [3] . For tumor tissue there are still no reference values available, but [4] and [5] provide an informative basis to appraise the difference between tumorous and healthy liver tissue.
For the treatment of hepatic malignancies it is much more difficult to create a homogeneous field because of the different electrical properties of healthy and diseased liver tissue and their 3D geometry (see Fig. 1 and the prototype in Fig. 2 ). For this purpose an electrode for percutaneous application had to be developed: It is designed in a CAD environment (SolidWorks 2012) with a live-link to a FEM simulation software (Comsol 4). Changes in design can be revalued quickly, regarding different quality criteria for field strength inside and outside the tumor. To rate these criteria, a set of formulas has been developed. (Fig. 1) .
Results
The quality factor G is defined as a value between G min = 0 and G max = 100, which would be the ideal case: The solid tumor ( Volume V T ) is fully porated (reversible/irreversible), boundary areas (Volume V R ) are reversible porated and healthy tissue (everywhere outside V T + V R ) are not harmed at all. With weighting coefficients the physician can tune the quality factor for his own needs. E.g.: It is significantly worse to leave even small areas of the tumor tissue unharmed than to porate some healthy tissue. A bigger, unporated boundary volume segment will increase the quality factor more than a small one. The quality factor is set to G min := 0, if solid tumor is not porated completely (V T,unp = 0) or if more than p [in %] of the boundary area is still unporated. Summarizing, the quality factor is a sum of weighted coefficients, which describe events, that should not occur. These events -respectively these coefficients -decreases the quality factor down from G max = 100. The relevant different cases for calculating G, subdivided in the different volume segments, with preselected weighting coefficients are shown in 1.
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Discussion
With the calculated value of G different geometry parameters, different wiring of the electrode or different voltages can be determined and compared to each other. With this value we are able to optimize the electrode to any (different) kind of tumor ans we can determine how precisely the production line has to keep/maintain the geometric parameters. Also the physician is able to optimize place for pushing the 
